For people on older drugs that disable the body's main tyramine-clearing enzyme, strictly avoiding high-tyramine foods such as aged cheese and cured meats is essential and potentially life-saving. For everyone else, the body clears tyramine efficiently and broad health benefit is largely unsupported; targeting only genuinely high-tyramine foods captures most value while avoiding over-restriction. (Full Review)

Protocol

Approach

Targeted, not comprehensive

Restrict only reliably high-tyramine foods; permit the majority of foods on legacy lists.

Match to medication

Scale strictness to the drug

Irreversible inhibitor warrants strict avoidance; a RIMA or low-dose selegiline patch may need little or none.

Meal structure

Avoid large single-meal load

Pressor risk is dose-dependent within a meal; spread any permitted moderate-tyramine foods across meals.

Time to effect

MAO-inhibitor users

Immediate

Protective effect begins as soon as high-tyramine foods are excluded.

Suspected headache trigger

2–4 weeks

Any benefit typically becomes apparent over a 2–4 week elimination period.

Benefits

High: Prevention of hypertensive crisis in users of irreversible MAO inhibitors

Medium: Reduction of headache frequency in identified tyramine-sensitive migraine sufferers

Speculative: Symptom relief in food-amine intolerance; general cardiovascular or longevity benefit in healthy adults

Contraindications

Irreversible non-selective MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid)

High-dose selegiline

Key Interactions

MAO-B-selective and transdermal selegiline; rasagiline

Reversible inhibitors of MAO-A (RIMAs, such as moclobemide)

OTC sympathomimetics (decongestants such as pseudoephedrine, phenylephrine)

Supplemental tyrosine or phenylalanine; adrenergic stimulant supplements (bitter orange/synephrine, octopamine, hordenine); high-dose caffeine

Risk & Side Effects

Medium: Nutritional and dietary narrowing from over-restriction; loss of fermented-food benefits

Low: Psychological burden and disordered-eating risk

Speculative: Rebound or heightened sensitivity after prolonged strict avoidance

Monitoring

Marker	Target	Why
Blood pressure (systolic/diastolic)	~110–120 / 70–80 mmHg at rest	Primary safety marker; detects pressor reactions and baseline hypertension
Heart rate	60–80 bpm at rest	Accompanies sympathetic activation during a tyramine reaction
MAO-A / OCT1 / CYP2D6 genotype	Normal-activity variants	Explains individual susceptibility to intact-tyramine exposure
Plasma free metanephrines/normetanephrine	Within laboratory reference range	Helps distinguish a tyramine pressor reaction from other catecholamine-excess causes when a crisis is investigated

Cadence: On an irreversible MAO inhibitor, check blood pressure at baseline, within the first 1–2 weeks, then periodically (e.g., every 3–6 months); for a symptom-driven elimination trial, keep a daily symptom diary across the 4-week elimination and reintroduction phase.

Qualitative Assessment

Absence of hypertensive-crisis symptoms (sudden severe headache, neck stiffness, sweating, palpitations) in medicated users
Reduction in frequency or severity of food-associated headaches in those restricting for migraine
Maintained dietary variety, adequate protein intake, and stable body weight, indicating the restriction is not causing nutritional narrowing
General energy, well-being, and absence of food-related anxiety, indicating the regimen is sustainable

Avoiding Tyramine for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment